"Amobarbital" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A barbiturate with hypnotic and sedative properties (but not antianxiety). Adverse effects are mainly a consequence of dose-related CNS depression and the risk of dependence with continued use is high. (From Martindale, The Extra Pharmacopoeia, 30th ed, p565)
| Descriptor ID |
D000654
|
| MeSH Number(s) |
D03.383.742.698.253.077
|
| Concept/Terms |
Amobarbital Sodium- Amobarbital Sodium
- Sodium, Amobarbital
- Sodium Amobarbital
- Amobarbital, Sodium
|
Below are MeSH descriptors whose meaning is more general than "Amobarbital".
Below are MeSH descriptors whose meaning is more specific than "Amobarbital".
This graph shows the total number of publications written about "Amobarbital" by people in this website by year, and whether "Amobarbital" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1991 | 0 | 1 | 1 |
| 1992 | 1 | 0 | 1 |
| 1993 | 0 | 1 | 1 |
| 1994 | 0 | 1 | 1 |
| 1995 | 2 | 0 | 2 |
| 1996 | 0 | 1 | 1 |
| 1997 | 1 | 0 | 1 |
| 1998 | 1 | 0 | 1 |
| 1999 | 0 | 1 | 1 |
| 2000 | 1 | 1 | 2 |
| 2002 | 5 | 4 | 9 |
| 2003 | 4 | 5 | 9 |
| 2004 | 5 | 5 | 10 |
| 2005 | 3 | 1 | 4 |
| 2006 | 5 | 6 | 11 |
| 2007 | 2 | 1 | 3 |
| 2008 | 4 | 3 | 7 |
| 2009 | 2 | 5 | 7 |
| 2010 | 2 | 1 | 3 |
| 2011 | 3 | 2 | 5 |
| 2012 | 4 | 2 | 6 |
| 2013 | 3 | 1 | 4 |
| 2014 | 1 | 2 | 3 |
| 2015 | 2 | 2 | 4 |
| 2016 | 0 | 1 | 1 |
| 2017 | 1 | 0 | 1 |
| 2018 | 0 | 1 | 1 |
| 2019 | 1 | 0 | 1 |
| 2020 | 0 | 2 | 2 |
To return to the timeline, click here.
Below are the most recent publications written about "Amobarbital" by people in Profiles.
-
Drugs Repurposing Using QSAR, Docking and Molecular Dynamics for Possible Inhibitors of the SARS-CoV-2 Mpro Protease. Molecules. 2020 Nov 06; 25(21).
-
Systemic steroids in patients with COVID-19: pros and contras, an endocrinological point of view. J Endocrinol Invest. 2021 Apr; 44(4):873-875.
-
How amytal changed psychopharmacy: off-label uses of sodium amytal (1920-40). Hist Psychiatry. 2019 09; 30(3):352-358.
-
Diagnostic accuracy of functional magnetic resonance imaging, Wada test, magnetoencephalography, and functional transcranial Doppler sonography for memory and language outcome after epilepsy surgery: A systematic review. Epilepsia. 2018 12; 59(12):2305-2317.
-
Comparing the Intracarotid Amobarbital Test and Functional MRI for the Presurgical Evaluation of Language in Epilepsy. Curr Neurol Neurosci Rep. 2017 Jul; 17(7):54.
-
[Attempted suicide with barbiturates purchased online]. Ned Tijdschr Geneeskd. 2016; 160:D491.
-
Dexmedetomidine Sedation for WADA Test With Intracarotid Propofol in Pediatric Patients. J Neurosurg Anesthesiol. 2015 Oct; 27(4):352-3.
-
Propofol as a substitute for amobarbital in Wada testing. J Clin Neurosci. 2015 Nov; 22(11):1830-2.
-
Mitochondria and NADPH oxidases are the major sources of TNF-a/cycloheximide-induced oxidative stress in murine intestinal epithelial MODE-K cells. Cell Signal. 2015 Jun; 27(6):1141-58.
-
Menstrual cycle corrupts reliable and valid assessment of language dominance: Consequences for presurgical evaluation of patients with epilepsy. Seizure. 2015 May; 28:26-31.